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Abstract: Idiopathic intracranial hypertension (IIH) in pregnancy is often responsive to 
conservative management and usually carries a favorable prognosis. Pregnant patients may be 
managed with dietary control, corticosteroid therapy, diuretics, and occasionally serial lumbar 
puncture. We report an unusual case of permanent visual loss due to IIH in pregnancy, requiring 
aggressive CSF diversion and bilateral optic nerve sheath fenestration after failure to improve 
with a brief course of medical management and a lumbar puncture. Despite resolution of the 
papilledema, the subject’s acuity improved only to 20/40 in the right eye and remained no light 
perception in the left eye.
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Introduction
Idiopathic intracranial hypertension (IIH) in pregnancy is often responsive to 
conservative management and usually carries a favorable prognosis. Pregnant patients 
may be managed with dietary control, corticosteroid therapy, diuretics, and occasionally 
serial lumbar puncture. The following case represents an unusual report of permanent 
visual loss due to IIH in pregnancy, which required aggressive cerebrospinal ﬂuid 
diversion and bilateral optic nerve sheath fenestration.
Methods
Retrospective chart, radiographic, and photographic review.
Case report
A 22 year-old African American (G6P2, no spontaneous fetal loss) with a 13 week 
intrauterine pregnancy was transferred to our facility for further management of IIH. 
During her uncomplicated pregnancy, the patient gained approximately two pounds 
from a prepartum weight of 155 lbs. (prepartum body mass index = 28). The past 
medical history was otherwise unremarkable. A sister had systemic lupus erythematos. 
The patient took an oral contraceptive for six months prior to the pregnancy, and a 
daily prenatal vitamin during the pregnancy.
At gestational week 12, she presented to a local emergency department with 
complaints of headache and blurred vision for approximately one day. She was 
treated with acetaminophen/hydrocodone over the next six days. Despite treatment, 
the patient developed worsening headache and blurred vision, photophobia, dizziness, 
nausea, vomiting, and muscle stiffness and spasm in the neck and trapezius. She 
remained afebrile throughout her entire course. Her visual acuity at that time was 
reported as 20/100 in the right eye and light perception in the left eye. A computed 
tomographic (CT) scan without contrast and magnetic resonance venography 
(MRV), were both normal. She underwent a lumbar puncture in the lateral recumbent 
position with an opening pressure of 460 mmH2O. Cerebrospinal ﬂuid (CSF) studies, Clinical Ophthalmology 2007:1(2) 100
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including cytology, Gram stain, culture, cryptococcus antigen, 
and stain for acid-fast bacilli, were normal (protein = 32; 
glucose = 69; leukocytes = 2; 92% lymphocytes; red blood 
cells [RBC] = 1). The patient was treated with 250 mg 
intravenous methylprednisolone succinate every six hours 
and ceftriaxone. Other hematological values at that time 
included hemoglobin of 12.6 gram/deciliter, hematocrit of 
36.4%, leukocyte count of 10.4 × 10−9/liter (L) and a platelet 
count of 274 × 10−9/L. A serum rapid plasma reagin was 
nonreactive.
The patient was transferred to our facility for further 
management. Best corrected visual acuities were 20/100 in 
the right eye and no light perception (NLP) in the left 
eye. The patient correctly identiﬁ  ed 10/10 Ishihara color 
plates with the right eye. The left pupil failed to react to 
light, although the efferent response was intact. Humphrey 
24-2 fastpac visual ﬁ  eld testing of the right eye revealed 
a mean deviation of −16.1. There was an enlarged blind 
spot, dense nasal depression, and peripheral constric-
tion (Figure 1). Extraocular movements were full, and 
the patient was orthophoric by Hirschberg testing. Slit 
lamp examination was noncontributory. Dilated fundu-
scopic examination revealed moderately severe, bilateral 
papilledema without evidence of vitritis or other retinal 
disturbances (Figure 2).
The patient was admitted to the high-risk obstetrics 
service with the diagnosis of IIH. Review of previous imaging 
studies (CT, MRV), and a subsequent high quality magnetic 
resonance image of the brain and orbits with fat suppression 
and contrast at our facility, revealed no abnormalities. 
Speciﬁcally, there was no hydrocephalus, mass lesion, 
meningeal or optic nerve enhancement. Her systolic blood 
pressure ranged from 104 to 137 mm of mercury (mmHg) 
and the diastolic from 55 to 60 mmHg.
Additional studies included: Westergren erythrocyte 
sedimentation rate (ESR) = 62 mm/hour (hr); normal thyroid 
function panel; protein C = 175 (normal range: 60–140); 
activated partial thromboplastin time = 23.7 seconds, and 
an equivocal Lyme screen. Relevant coagulation measures, 
including homocysteine level, protein S activity, Dilute 
Russel viper venom, and anticardiolipin IgG and IgM, were 
all normal. C-reactive protein and antinuclear antibody were 
normal. In addition, the patient had negative serologies 
for human immunodeﬁciency virus and hepatitis C. 
A tuberculosis skin test was negative. A hemoglobin 
electrophoresis was normal.
The patient received a gram of methylprednisolone 
succinate per day in divided doses. One day after admission, 
she underwent a bilateral ONSF and concurrent placement 
of a lumbar drain (5 ml/hr). Microscopic evaluation of 
specimens of the right and left optic nerve sheaths was 
normal. Gram stain and culture of the CSF bag specimen 
obtained during drainage were unremarkable, and repeated 
analysis revealed only rare lymphocytes, 31 RBC, and normal 
protein and glucose levels. The CSF VDRL was negative. 
The lumbar drain was removed on post-operative day three 
and the patient was discharged home on post-operative day 
four on 60 mg of prednisone.
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Figure 1 Humphrey 24-2 visual ﬁeld testing with mean deviation of −16.1; right eye.Clinical Ophthalmology 2007:1(2) 101
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In follow-up, the visual acuity in the right eye improved 
to 20/40 and remained NLP in the left eye. The patient’s 
funduscopic examination showed resolution of disc edema 
but pallor developed bilaterally (Figure 3).
Discussion
The patient’s course and tempo of visual loss is unusual 
for IIH. Extensive hematological, serologic, and struc-
tural evaluation for other causes of elevated intracranial 
pressure was unrevealing. Specifically, there was no 
evidence of meningitis, inflammatory optic neuropathy 
nor venous sinus thrombosis. Three laboratory abnor-
malities deserve further discussion. An elevated ESR 
was felt to be secondary to pregnancy rather than due to a 
primary inﬂ  ammatory or viral process. A recent study by 
van den Broe and colleagues (2001) concluded that ESR 
ranges for pregnant patients vary with gestational age and 
hemoglobin level. For anemic patients in the ﬁ  rst half of 
A
B
Figure 2 Severe disc edema, splinter hemorrhage, venous tortuosity, nerve ﬁber layer opaciﬁcation and cotton-wool spots; A, right eye; B, left eye.Clinical Ophthalmology 2007:1(2) 102
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pregnancy, ESR is expected to be in the range of 40 to 
95 mm per hour. Thus, the ESR was within normal limits for 
the patient’s stage of pregnancy. Secondly, according to a 
prospective study by Oruc and colleagues (2000), Protein C 
and Protein S anti-coagulant proteins typically decrease 
during a normal pregnancy on a dilutional basis. It is possible 
that the modest elevation in protein C in this case represents 
an acute phase response. Finally, the equivocal Lyme testing 
did not meet the Center for Disease Control and Prevention 
criteria for the diagnosis of Lyme disease.
More than 70 cases (Nickerson and Kirk 1965; Elian et al 
1968; Powell 1972; Caroscio and Pellmar 1978; Shekleton 
et al 1980; Anderson 1983; Kassam et al 1983; Koontz et al 
1983; Digre et al 1984; Peterson and Kelly 1985; Katz et al 
1989; Shapiro et al 1995; Evans and Friedman 2000; 
Huna-Baron and Kupersmith 2001) of IIH during pregnancy 
are reported in the English language since 1960. A review 
of these reports revealed no case of blindness and only 
a handful of reported cases of permanent visual ﬁeld loss 
(Nickerson and Kirk 1965; Powell 1972; Shekleton et al 1980; 
A
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Figure 3 Signiﬁ  cant decrease of papilledema three days following ONSF and placement of lumbar drain; A, right eye; B, left eye.Clinical Ophthalmology 2007:1(2) 103
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Shapiro et al 1995). Our patient was unique in that she not 
only experienced permanent loss of visual acuity and visual 
ﬁeld, but the onset and magnitude of loss was both rapid 
and extreme. This type of clinical progression of IIH in 
pregnancy is not typically reported. Furthermore, based on 
the cases presented in the literature, IIH in pregnancy is often 
responsive to conservative management with diet, bed rest, 
steroids, diuretics or lumbar puncture(s) (Nickerson and Kirk 
1965; Powell 1972; Caroscio and Pellmar 1978; Alderson 
1983; Kassam et al 1983; Koontz et al 1983; Digre et al 
1984; Peterson and Kelly 1985; Katz et al 1989; Huna-Baron 
and Kupersmith 2001). Only a minority of cases requires 
aggressive therapy involving surgical intervention. In our 
case, conservative medical management failed and carbonic 
anhydrase inhibitors were not used because of their relative 
contraindication in pregnancy (category C: animal studies 
show adverse fetal effects[s]; no controlled human studies). 
Thus, rapid surgical intervention was needed to halt the 
progressive visual loss and probably contributed to ultimate 
improvement in visual acuity and ﬁeld in the right eye.
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